rho-conopeptide alpha-1 adrenoceptor antagonists (Xenome)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerho-conopeptide alpha-1 adrenoceptor antagonists (Xenome)
Drug Alias Namerho-TIArho-conotoxin alpha-1 adrenoceptor antagonists (Xenome/University of Queensland)
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsCardiovascular DiseasesUrination Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesUrination Disorders

Other Information

ATC CodeN/A
Related LinksN/A